American Bio Medica
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of American Bio Medica generated cash of -$768,000, which is less than the previous year. Cash used in financing activities reached the amount of $687,000 last year. Net change in cash is therefore -$81,000.
Cash Flow
| 2013 | 9K | -34K | 582K |
|---|---|---|---|
| 2014 | 98K | -65K | -327K |
| 2015 | 230K | -21K | -403K |
| 2016 | 241K | -30K | -213K |
| 2017 | 181K | -64K | -237K |
| 2018 | -220K | -22K | 319K |
| 2019 | 58K | 0 | -167K |
| 2020 | -483K | -4K | 581K |
| 2021 | -673K | 0 | 690K |
| 2022 | -768K | 0 | 687K |
ABMC Cash Flow Statement (2013 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 115K | 98K | 4K | 113K | 36K | 156K | 158K | 352K | 646K | 89K |
Operating activities | ||||||||||
Net income | -1.41M | -463K | -796K | -681K | -1.02M | -545K | -345K | -333K | -490K | -788K |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 51K | 68K | 79K | 81K | 81K | 80K | 91K | 91K | 111K | 116K |
Stock-based compensation expense | 0 | 0 | 2K | 6K | 0 | 43K | 61K | 34K | 139K | 257K |
| Deferred income tax benefit | 0 | 0 | 2K | 6K | 0 | 43K | 61K | 34K | 139K | 257K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 242K | 103K | -40K | 84K | -88K | 205K | 116K | 139K | 50K | -63K |
Inventories | 107K | 92K | 117K | 113K | 320K | 58K | 147K | -132K | 334K | 363K |
Accounts payable | 78K | 105K | -75K | 293K | -15K | 70K | -39K | -37K | -187K | -420K |
Cash generated by operating activities | -768K | -673K | -483K | 58K | -220K | 181K | 241K | 230K | 98K | 9K |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | 0 | -4K | 0 | -22K | -64K | -30K | -21K | -75K | -34K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 0 | 0 | -4K | 0 | -22K | -64K | -30K | -21K | -65K | -34K |
Financing activities | ||||||||||
Common Stock Issued | 0 | 100K | 199K | 0 | 200K | 0 | 0 | 0 | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 687K | -2.24M | -4.05M | -167K | -4.16M | -237K | -6.15M | -253K | -6.61M | -9.22M |
Cash used in financing activities | 687K | 690K | 581K | -167K | 319K | -237K | -213K | -403K | -327K | 582K |
Net Change In Cash | -81K | 17K | 94K | -109K | 77K | -120K | -2K | -194K | -294K | 557K |
Cash at end of period | 34K | 115K | 98K | 4K | 113K | 36K | 156K | 158K | 352K | 646K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |